Navigation Links
Angiotensin-II-receptor blockers - Treat kidney failure

Drugs used to treat high blood pressure have been found to also help slow the progress of kidney failure. Three separate drug trials reveal that the angiotensin-II-receptor blockers, which include losartan and irbesartan, can be used to treat kidney failure, one of the commonest complications in diabetes. //

In the first trial, carried out by doctors in Boston, USA, 1500 patients with type 2 diabetes and kidney disease were given either losartan or placebo. After three years of follow up, the losartan group had a 28 per cent lower risk of end-stage kidney disease. This is equivalent to delaying the need for dialysis or transplantation by two years.

The second trial involved researchers in Chicago who found that the progression of kidney disease or death was reduced by around 20 per cent in patients on irbesartan. Even those with advanced disease could benefit, although the treatment is best started early on. A final study of irbesartan on diabetic patients with early signs of kidney disease showed the condition was less likely to progress than in similar patients on placebo. The trials offer new hope to people with diabetes, for there has been no treatment for kidney complications till now. They also underline the need for the earliest possible diagnosis of kidney disease in people with diabetes.


'"/>




Page: 1

Related medicine news :

1. Calcium-blocker delays atherosclerosis than beta-blockers
2. Evidence against use of Beta blockers as first choice in the treatment of primary hypertension
3. Alpha-blockers call for modification in cataract surgery
4. Advances in Treatment of Cataracts
5. Recommendations for Treatment of Blood Pressue
6. New FDA Approved Drug To Treat Migraine
7. Treatment for Menieres disease
8. Treatment for pre-menstrual syndrome is ineffective
9. Cipro Has Cheaper Cousins to Treat Anthrax
10. Better Treatment for obesity
11. Gene Treatment for Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2017)... ... January 24, 2017 , ... OMI Industries, ... officially formed a distribution partnership with Byers Scientific & Manufacturing , a ... , Through the agreement, OMI Industries formulated a special version of Ecosorb® for ...
(Date:1/24/2017)... ... January 24, 2017 , ... Center for Hispanic Leadership (CHL) ... named Hector M. Chavez, Manager, Employee & Labor Relations at City of Hope ... Hispanic Leader of the Month. City of Hope is committed to stay out in ...
(Date:1/24/2017)... ... January 24, 2017 , ... The University of Iowa, ... great care to design a program that provides teachers with the specific skills and ... online teaching certificate is ideal for post-baccalaureate students and HigherEducation.com is working to ensure ...
(Date:1/24/2017)... ... January 24, 2017 , ... The NewKILO JRP, a three-year project of the ... the European Union (EU), was completed in May 2015. The future definition will require ... used in air, which presents some challenges to establishing traceability to the mass scale. ...
(Date:1/24/2017)... ... January 24, 2017 , ... Today, Taza Agua, Costa ... bottles, designed specifically to optimize the drinking experience for K-Cup coffee, tea and ... introducing the world’s first untouched bottled water purposed exclusively for creating a superior ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... GERMANTOWN, Md. , and GAITHERSBURG, Md. ... XON ), a leader in the engineering and ... health of the planet, today announced that it has entered ... (NASDAQ: GNVC ), a clinical-stage company and pioneer ... Intrexon intends to integrate and expand upon GenVec,s expertise ...
(Date:1/24/2017)... , January 24, 2017 www.Financialbuzz.com ... growing industries in the United States ... in 2016. In addition, Proposition 64, the California Cannabis Legalization ... 42.87% against on November 8, 2016. This outcome means that ... use and to grow a certain amount of cannabis for ...
(Date:1/24/2017)...   QR Pharma , Inc., a privately ... for the treatment of Alzheimer,s, Parkinson,s and other ... world-class key opinion leaders to its Scientific Advisory ... previous roster of impressive advisors in order to ... development of the breakthrough mechanism of action of ...
Breaking Medicine Technology: